Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Matador Resources Q1 2026 Earnings Call - Production Up, Debt Down, and Capital Discipline Held Firm Amid Chaos
Matador Resources delivered a resilient first quarter in 2026, proving that operational discipline and integrated midstream assets can shield an E&P company from macroeconomic volatility. CEO Joe Fora...
- Production growth outpaced first half of 2025, driven by well outperformance and accelerated activity, even as full-year capital spending remained flat or slightly down.
- Debt reduction continues, placing the balance sheet in the strongest position of the company’s 40-year history, according to CEO Joe Foran.
- Management prioritized “profitable growth at a measured pace,” rejecting reckless capital deployment despite a lack of balance sheet constraints.
- +7 more takeaways
Grupo Supervielle Q1 2026 Earnings Call - Underlying Profitability Returns as Credit Costs Peak and Cost Base Shrinks
Grupo Supervielle delivered a pivotal first quarter of 2026, marking the return of underlying profitability after a strategic rightsizing initiative. Excluding ARS 23.8 billion in severance charges fr...
- Underlying profitability returned in Q1 2026, with adjusted net income of ARS 6.7 billion after excluding ARS 23.8 billion in severance charges from a voluntary retirement and headcount reduction plan.
- Cost of risk fell 400 basis points to 6%, down from 10.4% in Q4 2025, reinforcing management’s view that credit costs peaked in the fourth quarter of 2025.
- NPL ratio stood at 5.6% at quarter-end, having peaked in February, with early signs of stabilization through March driven by stricter origination and enhanced collection initiatives.
- +7 more takeaways
Certara Q1 2026 Earnings Call - Exiting Medical Writing to Double Down on AI-Driven Drug Development
Certara exited the listening phase and is now executing a sharp pivot toward AI-integrated clinical intelligence, driven by a new organizational structure and a strategic divestiture. The company sold...
- Certara divested its regulatory and medical writing business to Veristat, a move designed to eliminate lumpy revenue streams and sharpen focus on its core technology and scientific advantages.
- The company reorganized into two distinct growth units: MID3 (Model-Informed Drug Development and Discovery) and ACE (Accelerated Clinical Evidence), aiming to create a flywheel between technology and expert services.
- Software bookings surged 20% year-over-year to $48.7 million, driven by strong performance across all customer tiers and new product releases in Phoenix Cloud and Simcyp.
- +7 more takeaways
Mammoth Energy Services Q1 2026 Earnings Call - First Positive EBITDA in Two Years Drives Full-Year Profitability Pull-Forward
Mammoth Energy Services delivered its first positive Adjusted EBITDA in eight quarters, with Q1 2026 revenue surging 90% year-over-year to $22 million. The turnaround, driven by a disciplined cost res...
- Mammoth reported Q1 2026 revenue of $22 million, a 90% year-over-year and 133% sequential increase, marking a clear inflection point in its turnaround strategy.
- Adjusted EBITDA turned positive at $1.9 million, the first positive quarter in eight quarters, driven by revenue growth and disciplined cost management.
- Management raised full-year 2026 guidance, now expecting full-year Adjusted EBITDA positivity and revenue growth exceeding 60%, accelerating the profitability timeline by a full year.
- +7 more takeaways
Endeavour Silver Q1 2026 Earnings Call - Record Production and Cash Flow Fuel Pitarrilla Ambitions
Endeavour Silver reported a record-breaking first quarter of 2026, driven by the full integration of the Kolpa plant expansion and the ramp-up of its new Terronera mine. Production surged 78% year-ove...
- Record Q1 2026 production of nearly 2 million ounces of silver and 12,000 ounces of gold, representing a 78% year-over-year increase.
- Revenue surged 230% to $210 million, while mine operating cash flow before taxes jumped 400% to $115 million.
- All-in sustaining costs net of byproduct credits rose 51% to $37 per ounce due to higher royalties and third-party material purchases at Terronera, but are expected to decline as operations stabilize.
- +7 more takeaways
LandBridge Q1 2026 Earnings Call - Raised 2026 Guidance on Data Center Momentum and Pipeline Visibility
LandBridge delivered strong Q1 2026 results, with revenue and adjusted EBITDA both up 16% year-over-year, and raised its full-year adjusted EBITDA guidance to $210-230 million. The company’s fee surfa...
- LandBridge raised full-year 2026 adjusted EBITDA guidance to $210-230 million, up $5 million at both ends, driven by improved pipeline visibility and a more supportive macro environment.
- Q1 2026 revenue reached $51 million, up 16% year-over-year, with adjusted EBITDA of $44.9 million and an 88% margin, reflecting durable, high-margin economics.
- Free cash flow surged 158% year-over-year to $40.9 million, with a 80% free cash flow margin, underscoring the asset-light, minimal capital expenditure model.
- +9 more takeaways
CoreCivic Q1 2026 Earnings Call - Updated 2026 Guidance Raised Despite Transient ICE Population Dip
CoreCivic delivered a strong first quarter of 2026, beating adjusted EPS and EBITDA estimates while raising full-year guidance. The results were driven by the activation of previously idle facilities,...
- Full-year 2026 adjusted EPS guidance raised to $1.53-$1.63 from $1.49-$1.59, and adjusted EBITDA raised to $453.8M-$461.8M from $437M-$445M.
- Q1 2026 adjusted EPS of $0.40 beat estimates by $0.12, and adjusted EBITDA of $110.1M beat estimates by $13.3M.
- Acquisition of Clinical Solutions Pharmacy (CSP) completed for $148M, adding a mail-order pharmacy service for correctional facilities.
- +7 more takeaways
Priority Technology Holdings Q1 2026 Earnings Call - High-Growth Payables and Treasury Segments Drive Margin Expansion and Earnings Beat
Priority Technology Holdings delivered a robust first quarter, with revenue climbing 11% year-over-year to $249.6 million and adjusted EPS jumping 27% to $0.28. The company’s strategic pivot toward hi...
- Revenue grew 11% year-over-year to $249.6 million, driven by 9.1% organic growth and acquisitions completed in the second half of 2025.
- Adjusted EPS surged 27% to $0.28, outpacing revenue growth and reflecting improved margin mix from high-margin segments.
- Payables revenue jumped 35.6% year-over-year, fueled by larger enterprise clients using the platform for working capital and cross-border payments.
- +12 more takeaways
Patria Q1 2026 Earnings Call - Fee-Earning AUM Surges 31% as Platform Diversifies and Debt Strategy Shifts
Patria’s first quarter 2026 results underscore a platform in transition, shifting from reliance on volatile performance fees toward predictable, market-valued assets. Fee-earning AUM jumped 31% year-o...
- Fee-earning AUM grew 31% year-over-year to $45.8 billion, with pro forma AUM reaching $47.5 billion after the WP Global Partners acquisition.
- Fundraising totaled $2.1 billion in Q1 2026, keeping the firm on track to beat its 2025 record of $7.7 billion and meet full-year guidance of $7 billion.
- Fee-related earnings rose 19% to $50.5 million, supporting reaffirmed full-year FRE guidance of $225 million to $245 million and a long-term margin target of 58% to 60%.
- +7 more takeaways
FS KKR Capital Corp Q1 2026 Earnings Call - KKR Deploys $600M to Stabilize FSK Amid NAV Decline
FS KKR Capital Corp. (FSK) reported a challenging first quarter of 2026, with its NAV declining 9.9% per share to $18.83, driven by legacy credit events, non-accrual placements, and mark-to-market pre...
- FSK’s NAV per share declined 9.9% in Q1 2026 to $18.83, resulting from specific credit events, non-accrual moves, and mark-to-market adjustments.
- KKR is launching a $150 million fixed-price tender offer for FSK shares at $11.00, a premium to recent trading levels, to provide liquidity and express confidence in intrinsic value.
- KKR will invest $150 million in FSK via cumulative convertible perpetual preferred stock, carrying a 5% cash or 7% PIK dividend rate and an initial conversion price of $18.83.
- +9 more takeaways